Blonanserin
It is an antipsychotic agent characterized by its strong blocking action and high selectivity against dopamine-2 receptors and serotonin-2 receptors. It has stronger blocking action to dopamine-2 receptors than to serotonin-2 receptors.Schizoprenia.
Oral; 8-24 mg per day.
With adrenaline, azoleantifungals or HIV infected patients, CNS depressants, comatose patients, hypersensitivity.
Paediatric: Data not sufficient. Pregnancy: Data not sufficient. Lactation: Data not sufficient. Elderly: Increased risk of Neuroleptic Malignant Syndrome.
Parkinson syndrome, akathisia, insomnia , increased blood prolactin levels, dyskinesia, somnolence, anxiety/irritability.
CYP3A4 inhibitors, levodopa.
Brand Name | Manufactured by |
---|---|
BLONASER | LIFECARE NEURO PRODUCT LTD. |
BLONITAS | INTAS PHARMACEUTICALS LTD. |
ELICIA | ZYDUS CADILA |